M Brian Arnold

Title: M Brian Arnold: Innovator in Neuroscience

Introduction

M Brian Arnold, based in Franklin, Indiana, is a notable inventor recognized for his contributions to the field of neuroscience. With a total of four patents under his name, Arnold has focused on developing compounds that hold promise in treating neurological disorders.

Latest Patents

Among his latest innovations, Arnold has patented compounds related to excitatory amino acid receptor antagonists. One of his inventions involves a specific formula that encompasses organic groups, pharmaceutically acceptable metabolically labile esters or amides, and salts. These compounds are designed to act as antagonists to L-glutamate at metabotropic excitatory amino acid receptors. Additionally, he has created novel decahydroisoquinoline compounds that serve as excitatory amino acid receptor antagonists, which may offer therapeutic benefits for various neurological conditions. His patents also include synthetic methods for the preparation of these decahydroisoquinolines, along with novel intermediates in their synthesis.

Career Highlights

M Brian Arnold has made significant strides in his career at Eli Lilly and Company, a leading pharmaceutical corporation. His work in the development of compounds for neurological applications showcases his dedication to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Arnold has collaborated with esteemed colleagues, including Paul Leslie Ornstein and Darryle D Schoepp. These collaborations have played a vital role in advancing research and innovation within the realm of neuroscience.

Conclusion

In conclusion, M Brian Arnold's contributions as an inventor and his innovative patented technologies make him a valuable asset in the field of neuroscience. His work continues to impact the development of treatments for neurological disorders, highlighting the importance of innovation in enhancing healthcare solutions.